Navigating the global pharmaceutical landscape with facilities across five continents. By 2021, the drug delivery market is forecasted to reach approximately $1,700 billion—rising from $1,200 billion in 2016—one report by Markets and Markets projects. An increase in demand for biologics, drug delivery technology, and the prominence of chronic diseases are expected to drive this movement…
Marchesini Group USA Celebrates 25 Years in Business
Could you describe your company’s history—specifically, what are some of your roots and founding principles? How has that affected where you are today? Roger Toll: Our founding principles are based on quality equipment and solutions, belief in our customers, and dedication to innovation: Quality Equipment and Solutions: Marchesini lines make their mark especially for their…
What’s Hot in Pharma: 4/23/17 – 4/29/17
DSCSA Implementation: A Wholesaler’s Perspective
Signed into law on November 27, 2013, the Drug Supply Chain Security Act (DSCSA) doesn’t just affect U.S. pharmaceutical manufacturers. It also will have an impact on wholesale distributors and third-party logistics providers. In particular, it will require the establishment of licensure standards and annual reporting of information to the FDA. By November 2019, distributors will…
CMO Roundtable: What’s Next for the Contract Manufacturing Industry
An exclusive roundtable with Cambrex and West Pharmaceutical Services, Inc. on contract manufacturing as a whole, how the space has changed, upcoming trends, as well as what the industry will look like in the coming years. 2016 saw a continued increase in outsourcing manufacturing operations to contract manufacturers in order for pharmaceutical companies to cut…
Compounding Pharmacies to Compete with Pharma Manufacturers?
Compounding Pharmacies to Compete with Pharma Manufacturers? As the media pressures the pharmaceutical industry to offer the same high-quality drugs at lower prices, industry experts actively seek ways to meet this growing demand. And the answer isn’t always from where you might expect. With companies such as Mylan making headlines for its price hike of…
A CDMO with Forensic Insight
A CDMO with Forensic Insight “Juniper Pharma Services was initially born as Molecular Profiles back in the late 90s,” said Claire Madden-Smith, BSc PhD, Senior Vice President, Juniper Pharma Services. “It was founded to take some higher-end analytical tools to understand how and why formulations were working and how and why formulations were failing.” A…
What’s Hot in Pharma: 1/15/17 – 1/21/17
Learn what’s trending by taking a look at last week’s most-viewed stories on Pharmaceutical Processing. No. 10 “Are You Ready for FDA Inspection of Your Disclosure Practices?“ No. 9 “Report: Prefilled Syringes Market to Reach $22.5B by 2025“ No. 8 “FDA Grants Fast Track for Muscular Dystrophy Treatment“ No. 7 “Biogen to Pay $1.25B in Licensing Agreement…
INTERPHEX: What’s in Store for 2017
It’s hard to believe that INTERPHEX 2017 is nearly here. Set to take place on March 21-23, INTERPHEX will be housed at the Javits Center in New York City. A number of companies have already committed to exhibiting at INTERPHEX, including MG America, Pall Life Sciences, MilliporeSigma, NJM Packaging, GE Healthcare, Thermo Fisher Scientific, and many more. The full list of 2017 exhibitors,…
Trump Moves to Repeal & Replace Obamacare in a Matter of Weeks
On Tuesday, President-elect Donald Trump announced his intention to repeal the Affordable Care Act (ACA), saying that he hopes to see Congress repeal it as soon as possible and pass a replacement health law. Trump moves to repeal Obamacare swiftly—within days—and have a replacement very shortly thereafter. “Long to me would be weeks,” Trump said, aiming to replace…